Matches in SemOpenAlex for { <https://semopenalex.org/work/W3151603365> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3151603365 abstract "Objective This study compares the anti-tumor effects of single and combination use of clarithromycin and tamoxifen on estrogen receptor (ER) positive breast cancer cell lines,BT-483 and MCF-7 as well as triple negative cell line,MBA-MD-231,which acts as a negative control.The effect of solid breast tumor inhibition by clarithromycin is also studied.Method BT-483,MCF-7 and MBA-MD-231 were cultured in 6-well plates in a 37 ℃ humidified incubator without CO2 for 24 h prior to the addition of the test drugs.The test groups were clarithromycin (Group 1),tamoxifen (Group 2),clarithromycin and tamoxifen (Group 3),and control (Group 4).Group 3 was prepared in 1 to 1 ratio at a concentration of 1.5 mmol/L clarithromycin and 25 μmol/L tamoxifen.On the other hand,1 mm3 solid breast tumors were submerged into various groups as above for 24 h.On the harvest day,the proliferation of cancer cells and solid breast tumor samples were measured by WST-1 proliferation reagent while ATP bioluminescence assay was employed to measure the metabolic rate of the three cell lines.Results The proliferation of BT-483 and MCF-7 was suppressed most by combination use of clarithromycin and tamoxifen with statistical significance.The two drugs did not have an inhibitory effect on the hormonal negative cancer cells.For solid breast tumor samples,all the test groups showed reduced metabolic rate as compared with the control group (P0.05).Conclusion Combination use of tamoxifen and clarithromycin are effective in suppressing cell proliferation and metabolism rate of breast cancer cells while single use of clarithromycin effectively inhibits the proliferation of solid breast tumor." @default.
- W3151603365 created "2021-04-13" @default.
- W3151603365 creator A5021321424 @default.
- W3151603365 date "2012-01-01" @default.
- W3151603365 modified "2023-09-23" @default.
- W3151603365 title "Application of single and combination therapy of clarithromycin and tamoxifen to suppress breast cancer cell proliferation and metabolism" @default.
- W3151603365 hasPublicationYear "2012" @default.
- W3151603365 type Work @default.
- W3151603365 sameAs 3151603365 @default.
- W3151603365 citedByCount "0" @default.
- W3151603365 crossrefType "journal-article" @default.
- W3151603365 hasAuthorship W3151603365A5021321424 @default.
- W3151603365 hasConcept C109541995 @default.
- W3151603365 hasConcept C121608353 @default.
- W3151603365 hasConcept C126322002 @default.
- W3151603365 hasConcept C134018914 @default.
- W3151603365 hasConcept C143998085 @default.
- W3151603365 hasConcept C185592680 @default.
- W3151603365 hasConcept C2776409635 @default.
- W3151603365 hasConcept C2776962512 @default.
- W3151603365 hasConcept C2777164284 @default.
- W3151603365 hasConcept C2777176818 @default.
- W3151603365 hasConcept C2994423619 @default.
- W3151603365 hasConcept C502942594 @default.
- W3151603365 hasConcept C530470458 @default.
- W3151603365 hasConcept C55493867 @default.
- W3151603365 hasConcept C62112901 @default.
- W3151603365 hasConcept C71924100 @default.
- W3151603365 hasConcept C98274493 @default.
- W3151603365 hasConceptScore W3151603365C109541995 @default.
- W3151603365 hasConceptScore W3151603365C121608353 @default.
- W3151603365 hasConceptScore W3151603365C126322002 @default.
- W3151603365 hasConceptScore W3151603365C134018914 @default.
- W3151603365 hasConceptScore W3151603365C143998085 @default.
- W3151603365 hasConceptScore W3151603365C185592680 @default.
- W3151603365 hasConceptScore W3151603365C2776409635 @default.
- W3151603365 hasConceptScore W3151603365C2776962512 @default.
- W3151603365 hasConceptScore W3151603365C2777164284 @default.
- W3151603365 hasConceptScore W3151603365C2777176818 @default.
- W3151603365 hasConceptScore W3151603365C2994423619 @default.
- W3151603365 hasConceptScore W3151603365C502942594 @default.
- W3151603365 hasConceptScore W3151603365C530470458 @default.
- W3151603365 hasConceptScore W3151603365C55493867 @default.
- W3151603365 hasConceptScore W3151603365C62112901 @default.
- W3151603365 hasConceptScore W3151603365C71924100 @default.
- W3151603365 hasConceptScore W3151603365C98274493 @default.
- W3151603365 hasLocation W31516033651 @default.
- W3151603365 hasOpenAccess W3151603365 @default.
- W3151603365 hasPrimaryLocation W31516033651 @default.
- W3151603365 hasRelatedWork W1481293208 @default.
- W3151603365 hasRelatedWork W1882528117 @default.
- W3151603365 hasRelatedWork W1971807925 @default.
- W3151603365 hasRelatedWork W1986087165 @default.
- W3151603365 hasRelatedWork W2015692861 @default.
- W3151603365 hasRelatedWork W2023448359 @default.
- W3151603365 hasRelatedWork W2149511909 @default.
- W3151603365 hasRelatedWork W2315972529 @default.
- W3151603365 hasRelatedWork W2342821721 @default.
- W3151603365 hasRelatedWork W2375754982 @default.
- W3151603365 hasRelatedWork W2383767488 @default.
- W3151603365 hasRelatedWork W2390656650 @default.
- W3151603365 hasRelatedWork W2400012476 @default.
- W3151603365 hasRelatedWork W2409926842 @default.
- W3151603365 hasRelatedWork W2604174508 @default.
- W3151603365 hasRelatedWork W2617818841 @default.
- W3151603365 hasRelatedWork W3107316156 @default.
- W3151603365 hasRelatedWork W3165668627 @default.
- W3151603365 hasRelatedWork W3184739865 @default.
- W3151603365 hasRelatedWork W2566624489 @default.
- W3151603365 isParatext "false" @default.
- W3151603365 isRetracted "false" @default.
- W3151603365 magId "3151603365" @default.
- W3151603365 workType "article" @default.